Skip to main content

Table 1 Experiment 1 vitrectomy patient demographics

From: A validated analysis pipeline for mass spectrometry-based vitreous proteomics: new insights into proliferative diabetic retinopathy

Plex

Study ID

Exp 1: analyzed individually or pooled

Experiment phenotype

Surgical indication

Sex

Age

Lens status

Past ocular history

PVD

Cataract

Other

1.1

203

Treated individually

CTL

ERM OS

M

69

Phakic

Yes

Yes

None

1.1

210

Treated individually

CTL

ERM OD

F

67

Phakic

Yes

Yes

None

1.1

298

Treated individually

CTL

ERM OD

M

73

Pseudophakic

Yes

Yes

None

1.1

322

Treated individually

CTL

ERM OD

F

66

Phakic

Yes

Yes

None

1.1

415

Treated individually

CTL

ERM OD

M

76

Pseudophakic

Yes

Yes

None

1.1

200

Pooled

CTL

ERM OD

M

78

Pseudophakic

Yes

Yes

None

1.1

254

Pooled

CTL

ERM OS

M

80

Phakic

Yes

Yes

None

1.1

278

Pooled

CTL

ERM OS

F

76

Pseudophakic

Yes

Yes

None

1.1

289

Pooled

CTL

ERM OD

F

59

Pseudophakic

Yes

Yes

None

1.1

297

Pooled

CTL

ERM OD

M

86

Pseudophakic

Yes

Yes

None

1.1

300

Pooled

CTL

ERM OD

F

58

Phakic

Yes

Yes

Optic disc drusen associated with ERM

1.1

330

Pooled

CTL

ERM OD

F

70

Phakic

Yes

Yes

Intraretinal cyst, pseudohole

1.1

342

Pooled

CTL

ERM OS

F

62

Pseudophakic

Yes

Yes

None

1.1

424

Pooled

CTL

ERM OS

F

50

Phakic

Yes

No

None

1.1

456

Pooled

CTL

ERM OD

F

67

Pseudophakic

Yes

Yes

None

  1. Clinical information for patients from whom individual control samples and Pool1 aliquots were obtained. ERM epiretinal membrane, OS oculus sinister (left eye), OD oculus dexter (right eye), PVD posterior vitreous detachment